Tata India Pharma & HealthCare Fund Direct Growth-1.22%

2Groww
-6.76%
1 Year Return
Equity
Sectoral/Thematic
2.0 star
6M
1Y
3Y
All

Fund Details

Tata India Pharma & HealthCare Fund Direct Growth

RiskHigh
Min SIP Amount₹500
Expense Ratio1.15%
NAV9.2 (21 Aug 2019)
Fund Started28 Dec 2015
Fund Size168 Cr

Returns

1Y
3Y*
5Y*
Since inception*
Tata India Pharma & HealthCare Fund Direct Growth
-6.8%
-1.9%
NA
-2.4%
Category Average
-5.2%
-4.5%
3.9%
-
Rank within category
1
2
NA
-
*All returns are annualized.
SIP
Lumpsum
I want to invest per month5,000
    For how many years?
    1 Year
    3 Years
    Estimated Value
    as per Historical Returns
    30
    with -6.8% annual returns

    Comparison

    Data not available
    Pros
    1. Risk is lower compared to the benchmark
    2. 1Y Returns are higher than the benchmark
    3. 3Y Returns are higher than the benchmark
    Cons
    1. Asset under management(AUM) is less than 500 Crs. Watch expense ratio when AUM is very low
    2. Risk-adjusted returns are lower compared to the category

    Top Holdings

    NameSectorInstrument% Assets
    Sun Pharmaceutical Inds. Ltd.HealthcareEquity11.8%
    Dr. Reddy's Laboratories Ltd.HealthcareEquity11.4%
    Ipca Laboratories Ltd.HealthcareEquity9.9%
    Divi's Laboratories Ltd.HealthcareEquity9.7%
    Lupin Ltd.HealthcareEquity9.5%
    Abbott India Ltd.HealthcareEquity7.3%
    Procter & Gamble Health Ltd.HealthcareEquity7.3%
    Aurobindo Pharma Ltd.HealthcareEquity5.6%
    Alembic Pharmaceuticals Ltd.HealthcareEquity4.8%
    Sanofi India Ltd.HealthcareEquity4.5%
    See All

    Fund Managers

    addMeeta Shetty
    Education
    Ms. Shetty is Bachelor in Economics and CFA Charterholder
    Experience
    Prior to joining TATA Mutual Fund, she has worked with Kotak Securities, HDFC Securities, AMSEC(Asian Market Securities), Dalal & Broacha Stock Broking and karvey Stock Broking.
    Funds Managed

    Other Details

    Tata India Pharma & HealthCare Fund Direct Growth is a Equity Mutual Fund Scheme launched by Tata Mutual Fund. This scheme was introduced to investors on 28 Dec 2015. Rupesh Patel, Sonam Udasi is the Current Fund Manager of Tata India Pharma & HealthCare Fund Direct Growth.The fund currently has an Asset Under Management(AUM) of ₹168 Cr and the Latest NAV as of 21 Aug 2019 is ₹9.2.

    The Tata India Pharma & HealthCare Fund Direct Growth is rated High risk. Minimum SIP Investment is 500. Minimum Lumpsum Investment is 5000. Exit load of 0.25% if redeemed within 3 months.

    Investment Objective

    The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

    Tax Implications

    Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.

    Scheme Information Document(SID)

    ₹5000
    Min for First Investment
    ₹1000
    Min for Second Investment
    Exit load of 0.25% if redeemed within 3 months
    Exit Load

    Compare Funds

    Tata India Pharma & HealthCare Fund Direct Growth
    VS
    search

    About Tata Mutual Fund

    Address
    Mafatlal Centre, 9th Floor, Nariman Point Mumbai 400021
    Phone
    022 6657 8282
    Launch Date
    29 Jun 1995
    Website
    NA
    Tata Mutual Fund
    Asset Management Company
    Custodian
    Standard Chartered Bank
    Registrar & Transfer Agent
    Cams
    Address
    7th Floor, Tower II, Rayala Towers, 158, Anna Salai,
    Invest Now
    Enter investment amount
    + ₹1,000
    + ₹5,000
    + ₹10,000
    ONE TIME
    MONTHLY SIP
    Similar Funds
    Data not available
    Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing.
    Past performance is not indicative of future returns. Please consider your specific investment requirements, risk tolerance, investment goal, time frame, risk and reward balance and the cost associated with the investment before choosing a fund, or designing a portfolio that suits your needs.
    MOST POPULAR ON GROWW
    MUTUAL FUNDS COMPANIES: ICICI PRUDENTIAL  | HDFC  | RELIANCE  | ADITYA BIRLA SUN LIFE  | SBI  | UTI  | FRANKLIN TEMPLETON  | KOTAK MAHINDRA  | IDFC  | DSP BLACKROCK  | AXIS  | TATA  | L&T  | SUNDARAM  | DHFL PRAMERICA  | INVESCO  | LIC  | JM FINANCIAL  | BARODA PIONEER  | CANARA ROBECO  | HSBC  | IDBI  | INDIABULLS  | MOTILAL OSWAL  | BNP PARIBAS  | MIRAE ASSET  | PRINCIPAL  | BOI AXA  | UNION KBC  | TAURUS  | EDELWEISS  | ESSEL  | MAHINDRA  | QUANTUM  | PPFAS  | IIFL  | ESCORTS  |